SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-026162
Filing Date
2023-08-01
Accepted
2023-08-01 07:20:30
Documents
79
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 965500
2 ex31-1.htm EX-31.1 19256
3 ex31-2.htm EX-31.2 19233
4 ex32-1.htm EX-32.1 7127
5 ex32-2.htm EX-32.2 7151
  Complete submission text file 0001493152-23-026162.txt   4936581

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE xtnt-20230630.xsd EX-101.SCH 35971
7 XBRL CALCULATION FILE xtnt-20230630_cal.xml EX-101.CAL 64566
8 XBRL DEFINITION FILE xtnt-20230630_def.xml EX-101.DEF 128938
9 XBRL LABEL FILE xtnt-20230630_lab.xml EX-101.LAB 298988
10 XBRL PRESENTATION FILE xtnt-20230630_pre.xml EX-101.PRE 243911
73 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 741011
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 231129647
SIC: 2836 Biological Products, (No Diagnostic Substances)